Therapeutic applications of plasma exchange. 1988

C O Savage, and I Banks, and C D Pusey
Hammersmith Hospital, London.

Therapeutic plasma exchange has been used in a wide range of disorders in which circulatory macromolecules are thought to be pathogenic. In this review, we discuss briefly the practical aspects of the procedure, and consider the evidence for its benefit.

UI MeSH Term Description Entries
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D010951 Plasma Exchange Removal of plasma and replacement with various fluids, e.g., fresh frozen plasma, plasma protein fractions (PPF), albumin preparations, dextran solutions, saline. Used in treatment of autoimmune diseases, immune complex diseases, diseases of excess plasma factors, and other conditions. Exchange, Plasma,Exchanges, Plasma,Plasma Exchanges
D011696 Purpura, Thrombocytopenic Any form of purpura in which the PLATELET COUNT is decreased. Many forms are thought to be caused by immunological mechanisms. Purpura, Thrombopenic,Purpuras, Thrombocytopenic,Purpuras, Thrombopenic,Thrombocytopenic Purpura,Thrombocytopenic Purpuras,Thrombopenic Purpura,Thrombopenic Purpuras
D012035 Refsum Disease An autosomal recessive familial disorder that usually presents in childhood with POLYNEUROPATHY; SENSORINEURAL HEARING LOSS; ICHTHYOSIS; ATAXIA; RETINITIS PIGMENTOSA; and CARDIOMYOPATHIES. (From Joynt, Clinical Neurology, 1991, Ch37, p58-9; Rev Med Interne 1996;17(5):391-8) This condition can be caused by mutation in the genes encoding peroxisomal phytanoyl-CoA hydroxylase or proteins associated peroxisomal membrane, leading to impaired catabolism of PHYTANIC ACID in PEROXISOMES. HMSN Type IV,Heredopathia Atactica Polyneuritiformis,Neuropathy, Hereditary Motor and Sensory, Type IV,Phytanic Acid Storage Disease,Adult Refsum Disease,Classic Refsum Disease,HMSN 4,HMSN IV,Hemeralopia Heredoataxia Polyneuritiformis,Hereditary Motor And Sensory Neuropathy IV,Hereditary Motor and Sensory Neuropathy Type IV,Hereditary Motor and Sensory Neuropathy, Type IV,Hereditary Type IV Motor and Sensory Neuropathy,Phytanic Acid Oxidase Deficiency,Refsum Disease, Adult,Refsum Disease, Classic,Refsum Disease, Phytanic Acid Oxidase Deficiency,Refsum Disease, Phytanoyl-CoA Hydroxylase Deficiency,Refsum Syndrome,Refsum's Disease,Refsum's Syndrome,Refsum-Thiebaut Syndrome,Adult Refsum Diseases,Classic Refsum Diseases,Disease, Adult Refsum,Disease, Classic Refsum,Disease, Refsum,Disease, Refsum's,Diseases, Adult Refsum,Diseases, Classic Refsum,HMSN IVs,Heredoataxia Polyneuritiformis, Hemeralopia,Polyneuritiformis, Hemeralopia Heredoataxia,Polyneuritiformis, Heredopathia Atactica,Refsum Disease, Phytanoyl CoA Hydroxylase Deficiency,Refsum Diseases, Adult,Refsum Diseases, Classic,Refsum Thiebaut Syndrome,Refsum-Thiebaut Syndromes,Refsums Disease,Refsums Syndrome,Syndrome, Refsum,Syndrome, Refsum's,Syndrome, Refsum-Thiebaut,Syndromes, Refsum-Thiebaut
D001796 Blood Protein Disorders Hematologic diseases caused by structural or functional defects of BLOOD PROTEINS. Blood Protein Disorder,Disorder, Blood Protein,Disorders, Blood Protein,Protein Disorder, Blood,Protein Disorders, Blood
D002493 Central Nervous System Diseases Diseases of any component of the brain (including the cerebral hemispheres, diencephalon, brain stem, and cerebellum) or the spinal cord. CNS Disease,Central Nervous System Disease,Central Nervous System Disorder,CNS Diseases,Central Nervous System Disorders
D004700 Endocrine System Diseases Pathological processes of the ENDOCRINE GLANDS, and diseases resulting from abnormal level of available HORMONES. Endocrine Diseases,Diseases of Endocrine System,Disease, Endocrine,Disease, Endocrine System,Diseases, Endocrine,Diseases, Endocrine System,Endocrine Disease,Endocrine System Disease,System Disease, Endocrine,System Diseases, Endocrine
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006938 Hyperlipoproteinemia Type II A group of familial disorders characterized by elevated circulating cholesterol contained in either LOW-DENSITY LIPOPROTEINS alone or also in VERY-LOW-DENSITY LIPOPROTEINS (pre-beta lipoproteins). Hyperbetalipoproteinemia,Hypercholesterolemia, Essential,Hypercholesterolemia, Familial,Apolipoprotein B-100, Familial Defective,Apolipoprotein B-100, Familial Ligand-Defective,Familial Combined Hyperlipoproteinemia,Hyper-Low Density Lipoproteinemia,Hyper-Low-Density-Lipoproteinemia,Hyper-beta-Lipoproteinemia,Hypercholesterolemia, Autosomal Dominant,Hypercholesterolemia, Autosomal Dominant, Type B,Hypercholesterolemic Xanthomatosis, Familial,Hyperlipoproteinemia Type 2,Hyperlipoproteinemia Type IIa,Hyperlipoproteinemia Type IIb,Hyperlipoproteinemia, Type II,Hyperlipoproteinemia, Type IIa,LDL Receptor Disorder,Apolipoprotein B 100, Familial Defective,Apolipoprotein B 100, Familial Ligand Defective,Autosomal Dominant Hypercholesterolemia,Autosomal Dominant Hypercholesterolemias,Combined Hyperlipoproteinemia, Familial,Combined Hyperlipoproteinemias, Familial,Density Lipoproteinemia, Hyper-Low,Density Lipoproteinemias, Hyper-Low,Disorder, LDL Receptor,Disorders, LDL Receptor,Dominant Hypercholesterolemia, Autosomal,Dominant Hypercholesterolemias, Autosomal,Essential Hypercholesterolemia,Essential Hypercholesterolemias,Familial Combined Hyperlipoproteinemias,Familial Hypercholesterolemia,Familial Hypercholesterolemias,Familial Hypercholesterolemic Xanthomatoses,Familial Hypercholesterolemic Xanthomatosis,Hyper Low Density Lipoproteinemia,Hyper beta Lipoproteinemia,Hyper-Low Density Lipoproteinemias,Hyper-Low-Density-Lipoproteinemias,Hyper-beta-Lipoproteinemias,Hyperbetalipoproteinemias,Hypercholesterolemias, Autosomal Dominant,Hypercholesterolemias, Essential,Hypercholesterolemias, Familial,Hypercholesterolemic Xanthomatoses, Familial,Hyperlipoproteinemia Type 2s,Hyperlipoproteinemia Type IIas,Hyperlipoproteinemia Type IIbs,Hyperlipoproteinemia Type IIs,Hyperlipoproteinemia, Familial Combined,Hyperlipoproteinemias, Familial Combined,Hyperlipoproteinemias, Type II,Hyperlipoproteinemias, Type IIa,LDL Receptor Disorders,Lipoproteinemia, Hyper-Low Density,Lipoproteinemias, Hyper-Low Density,Receptor Disorder, LDL,Receptor Disorders, LDL,Type 2, Hyperlipoproteinemia,Type II Hyperlipoproteinemia,Type II Hyperlipoproteinemias,Type IIa Hyperlipoproteinemia,Type IIa Hyperlipoproteinemias,Xanthomatoses, Familial Hypercholesterolemic,Xanthomatosis, Familial Hypercholesterolemic

Related Publications

C O Savage, and I Banks, and C D Pusey
February 2015, Revista de neurologia,
C O Savage, and I Banks, and C D Pusey
January 1981, Progress in clinical and biological research,
C O Savage, and I Banks, and C D Pusey
March 2003, Turkish journal of haematology : official journal of Turkish Society of Haematology,
C O Savage, and I Banks, and C D Pusey
February 2014, Current opinion in anaesthesiology,
C O Savage, and I Banks, and C D Pusey
May 2000, Annals of internal medicine,
C O Savage, and I Banks, and C D Pusey
March 1984, The New England journal of medicine,
C O Savage, and I Banks, and C D Pusey
February 1999, Sangre,
C O Savage, and I Banks, and C D Pusey
January 1999, Acta medica Croatica : casopis Hravatske akademije medicinskih znanosti,
C O Savage, and I Banks, and C D Pusey
January 2001, Dynamics (Pembroke, Ont.),
C O Savage, and I Banks, and C D Pusey
January 1983, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!